{
  "id": "IF11217",
  "type": "CRS In Focus",
  "typeId": "IF",
  "number": "IF11217",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "Drug Pricing and the Law: Regulatory Exclusivities",
      "retrieved": "2020-09-05T09:14:47.646517",
      "id": "IF11217_1_2019-05-17",
      "formats": [
        {
          "filename": "files/2019-05-17_IF11217_e7095f4d16c3c07ce7a40e80a5edaac73af5195a.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/IF/IF11217/1",
          "sha1": "e7095f4d16c3c07ce7a40e80a5edaac73af5195a"
        },
        {
          "format": "HTML",
          "filename": "files/2019-05-17_IF11217_e7095f4d16c3c07ce7a40e80a5edaac73af5195a.html"
        }
      ],
      "date": "2019-05-17",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "IF",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=IF11217",
      "type": "CRS In Focus"
    }
  ],
  "topics": []
}